Abdullah Yesilyaprak

Abdullah Yesilyaprak

Auto-generated profile, based on publicly available information

Abdullah Yesilyaprak

Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute Cleveland Clinic Cleveland OH

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
AAAnkit Agrawal
Ankit Agrawal
SBSuryansh Bajaj
Suryansh Bajaj
UBUmesh Bhagat
Umesh Bhagat
AYAbdullah Yesilyaprak
Abdullah Yesilyaprak
Sanya ChandnaSanya Chandna
Sanya Chandna
EMErin D. Michos
Erin D. Michos
Background: Pregnancy in patients with pulmonary hypertension (PH) is associated with a heightened risk of medical complications including right heart failure, pulmonary edema, and arrhythmias. Our study investigated the association between PH and these complications during delivery. Methods and Results: The National Inpatient Sample was used to identify delivery hospitalizations from 2011 to 2020. Multivariable logistic regression was performed to study the association of PH with the primary outcomes of in‐hospital medical and obstetric complications. A total of 37 482 207 delivery hospitalizations in women ≥18 years of age were identified, of which 9593 patients had PH. Pregnant patients with PH had higher incidence of complications during delivery including preeclampsia/eclampsia, arrhythmias, and pulmonary edema among others, compared with those without PH. Pregnant patients with PH also had a higher incidence of in‐hospital mortality compared with those without PH (0.51% versus 0.007%). In propensity‐matched analyses, PH was still significantly associated with a higher risk of in‐hospital mortality (odds ratio [OR], 5.02 [95% CI, 1.82–13.90]; P =0.001), pulmonary edema (OR, 9.11 [95% CI, 6.34–13.10]; P <0.001), peripartum cardiomyopathy (OR, 1.85 [95% CI, 1.37–2.50]; P <0.001), venous thromboembolism (OR, 12.60 [95% CI, 6.04–26.10]; P <0.001), cardiac arrhythmias (OR, 6.11 [95% CI, 4.97–7.53]; P <0.001), acute kidney injury (OR, 3.72 [95% CI, 2.86–4.84]; P <0.001), preeclampsia/eclampsia (OR, 2.24 [95% CI, 1.95–2.58]; P <0.001), and acute coronary syndrome (OR, 2.01 [95% CI, 1.06–3.80]; P =0.03), compared with pregnant patients without PH. Conclusions: Delivery hospitalizations in patients with PH are associated with a high risk of mortality, pulmonary edema, peripartum cardiomyopathy, venous thromboembolism, arrhythmias, acute kidney injury, preeclampsia/eclampsia, and acute coronary syndrome.

16 November 2021 in Circulation
Verified
Journal Article
Closed access
AKAshwin K Kumar
Ashwin K Kumar
AYAbdullah Yesilyaprak
Abdullah Yesilyaprak
MFMuhammad M Furqan
Muhammad M Furqan
BVBeni Verma
Beni Verma
VJVardhmaan Jain
Vardhmaan Jain
AKAllan L Klein
Allan L Klein

27 November 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
JRJahanavi M Ramakrishna
Jahanavi M Ramakrishna
AYAbdullah Yesilyaprak
Abdullah Yesilyaprak
LMLea M Monday
Lea M Monday
GNGretchen Snoeyenbos Newman
Gretchen Snoeyenbos Newman
Both HIV and COVID-19 disproportionately affect vulnerable communities. People living with HIV (PLWH) are a priority population for COVID-19 vaccination. Bivalent COVID-19 boosters (BCB) were granted emergency use authorization on August 31, 2022. We assessed onsite BCB uptake amongst PLWH enrolled at our HIV clinic in Detroit, Michigan. HIV care data was obtained from CareWare collected as part of Ryan White program quality initiatives. BCB (Pfizer/BioNTech and Moderna) administration data from September 1, 2022 to March 20, 2023 was pulled using Current Procedural Terminology codes from our Athena electronic medical record. We excluded patients < 18 years old. A deterministic match was done using name and date of birth. Of 2268 PLWH, 1,921 (84.7%) had complete care data. The outcome of interest was the percentage of patients who received the BCB. Covariates examined were gender, age (years), race, CDC transmission risk factor, year of HIV diagnosis, insurance type, HIV viral load measurement after Sep. 1, 2022, and most recent HIV viral load value (< or > 200 copies/mL). Bivariate analysis was done using Wilcoxon rank sum test and Pearson's Chi-squared test. Statistical significance was defined as P < 0.05. We used R 4.3.0 for all analyses. Vaccine surveillance studies such as this one are critical to equitable vaccine distribution to PLWH by identifying subpopulations that may benefit from more intensive outreach. All Authors: No reported disclosures